2019
DOI: 10.5958/0974-360x.2019.01064.3
|View full text |Cite
|
Sign up to set email alerts
|

A Research on effective Management of Manufacturing defects to avoid Product Recalls: A Challenge to Pharmaceutical Industry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In contemporary healthcare marketing, the integration of data-driven strategies has emerged as a pivotal factor in optimizing efforts to achieve better health outcomes (Abhinaya et al, 2019). Leveraging a wealth of patient data, pharmaceutical companies and healthcare providers can tailor their marketing initiatives with precision, targeting specific demographics and tailoring messages to individual health needs.…”
Section: Data-driven Approaches To Enhance Health Marketingmentioning
confidence: 99%
“…In contemporary healthcare marketing, the integration of data-driven strategies has emerged as a pivotal factor in optimizing efforts to achieve better health outcomes (Abhinaya et al, 2019). Leveraging a wealth of patient data, pharmaceutical companies and healthcare providers can tailor their marketing initiatives with precision, targeting specific demographics and tailoring messages to individual health needs.…”
Section: Data-driven Approaches To Enhance Health Marketingmentioning
confidence: 99%
“…Table 6 shows that the results of a positive gap calculation in the availability of written procedures detailing product recall in response to customer complaints and all decisions and actions taken as a result of complaints are recorded and reffered to related batch records, as well as evaluating the effectiveness of the implementation of a recall has been routinely carried out. Drug withdrawal is carried out to return the product with the same batch or entire product to the factory because of the detection of safety problems or defects of the product [16]. In the aspect of "Handling complaints for products, recalling products and returning products" in the CPOTB, all complaints and information relating to the possibility of drug damage should be examined carefully in accordance with written procedures [2].…”
Section: Table 2 Manpower Fuzzificationmentioning
confidence: 99%
“…The CAPA system is the most frequently checked subsystem during regulatory audits. Inadequate investigations and CAPA systems and missing root cause analysis are the most frequently cited observations by regulators [4]. The CAPA system is an important component of an effective organization, and it must maintain a close relationship with its other quality subsystems.…”
Section: Introductionmentioning
confidence: 99%